• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Monolong
    / CTS


    Active Ingredient
    Isosorbide Mononitrate 40 mg, 60 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Slow-Release Capsules

    30 X 40 mg

    full basket chart 8282 13457

    Slow-Release Capsules

    30 X 60 mg

    full basket chart 8283 13458

    Related information


    Dosage

    One caplet or in severe cases two caplets a day.


    Indications

    Prophylaxis of angina pectoris.


    Contra-Indications

    Hypersensitivity.


    Special Precautions

    If organic nitrates are used in early infarction, hemodynamic monitoring and frequent clinical assessment should be conducted. Pregnancy and lactation. Nitrate therapy may aggravate the angina caused by hypertrophic cardiomyopathy, prudent to withdraw the drug gradually, not to misinterpret freedom from anginal attack as a signal to drop all restrictions.


    Side Effects

    Cutaneous vasodilation, flushing, headache, dizziness, palpitations, vertigo and weakness, paradoxical bradycardia and increased angina pectoris, rash and/or exfoliative dermatitis, nausea, vomiting, restlessness, pallor, perspiration and collapse.


    Drug interactions

    Phosphodiesterase inhibitors.


    Manufacturer
    CTS Chemical Industries Ltd
    CLOSE